サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1375080

医療用経皮吸収パッチ市場の欧州市場予測-地域別分析：タイプ、用途、流通チャネル別

Europe Transdermal Medical Patch Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, and Distribution Channel
出版日: | 発行: The Insight Partners | ページ情報: 英文 158 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
医療用経皮吸収パッチ市場の欧州市場予測-地域別分析：タイプ、用途、流通チャネル別
出版日: 2023年08月21日
発行: The Insight Partners
ページ情報: 英文 158 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の医療用経皮吸収パッチ市場は、2023年の24億3,409万米ドルから2028年には30億7,958万米ドルに成長すると予測されています。2023年から2028年までのCAGRは4.8%と推定されます。

慢性疾患の有病率の増加が欧州医療用経皮吸収パッチ市場を後押し

医療用経皮吸収パッチは、心臓病、脳卒中、糖尿病、がん、肥満、関節炎などの慢性疾患を患う人々に薬剤を投与するために使用されます。

心臓パッチは、細胞移植改善のための優れたプラットフォームを提供します。例えば、最近開発された血管新生心臓パッチは、虚血性心損傷の治療に有望な可能性を示しました。ニトログリセリン経皮パッチは、冠動脈疾患患者の狭心症（胸痛）エピソードを予防するために使用されます。ニトログリセリンは血管を弛緩させ、心臓への負担を軽減し、酸素の必要性を低下させる。ただし、このパッチはすでに始まっている狭心症発作の治療には使用できません。

リバスチグミンパッチは、軽度、中等度、重度のアルツハイマー病に伴う認知症（記憶障害）、またはパーキンソン病に伴う軽度から中等度の認知症の治療に使用されます。コリンエステラーゼ阻害薬であるリバスチグミンとドネペジルは用量反応関係を示し、高用量ほど高い効果を示します。リバスチグミンは小さく、親油性で親水性の分子であるため、化学的に経皮投与に適しています。リバスチグミン貼付剤の基礎となる技術は、その目立たないほど小さく薄い外観に寄与しています。したがって、リバスチグミン貼付剤は、高用量の効能を迅速かつ容易に利用することができます。

したがって、慢性疾患の有病率の増加は医療用パッチの需要を触媒します。

欧州医療用経皮吸収パッチ市場概要

欧州の医療用経皮吸収パッチ市場は、英国、ドイツ、スペイン、イタリア、その他欧州に区分されます。2022年、欧州の医療用経皮吸収パッチ市場で最大のシェアを占めたのは英国でした。慢性疾患やウイルス性疾患に罹患する患者数の増加、研究開発活動の活発化が医療用経皮吸収パッチ市場を推進している主な要因です。また、慢性疾患の有病率の増加も市場拡大を後押ししています。

欧州の医療用経皮吸収パッチ市場の収益と2028年までの予測（金額）

欧州の医療用経皮吸収パッチ市場のセグメンテーション

欧州の医療用経皮吸収パッチ市場は、タイプ、用途、流通チャネル、国に区分されます。

タイプ別では、単層薬剤接着剤、多層薬剤接着剤、リザーバー、蒸気パッチ、マトリックスに区分されます。2023年にはマトリックスセグメントが最大の市場シェアを記録しました。

用途別に見ると、欧州の医療用経皮吸収パッチ市場は、神経疾患、疼痛管理、ニコチン禁煙、心血管障害、ホルモン療法、その他に区分されます。疼痛管理分野が2023年に最大の市場シェアを占めました。

欧州の医療用経皮吸収パッチ市場は、流通チャネル別に病院薬局、小売薬局、オンライン薬局に区分されます。病院薬局セグメントが2023年に最大の市場シェアを占めました。

国別では、欧州の医療用経皮吸収パッチ市場はドイツ、フランス、英国、イタリア、スペイン、その他欧州に区分されます。2023年の市場シェアはドイツが独占しています。

Boehringer Ingelheim International GmbH、Endo International Inc、久光製薬株式会社、Johnsons and Johnsons、Medline Industries LP、Novartis AG、Teva Pharmaceutical Industries Ltd.、UCB SA、Viatris Incが、この地域の医療用経皮吸収パッチ市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 経皮吸収型医療用パッチ市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の医療用経皮吸収パッチ市場- 市場情勢

  • 概観
  • PEST分析
    • 欧州PEST分析
  • 専門家の見解

第5章 欧州の医療用経皮吸収パッチ市場：主要市場力学

  • 市場促進要因
    • 慢性疾患の有病率の増加
    • タバコ消費の増加
  • 市場抑制要因
    • 薬剤の不具合による医療用経皮吸収パッチのリコール
  • 市場機会
    • 戦略的イニシアチブの増加
  • 今後の動向
    • スマートパッチと3Dプリントパッチの進歩
  • インパクト分析

第6章 欧州の医療用経皮吸収パッチ市場：欧州分析

  • 欧州の医療用経皮吸収パッチ市場の収益と予測分析

第7章 欧州の医療用経皮吸収パッチ市場-2028年までの収益と予測- タイプ別

  • 欧州の医療用経皮吸収パッチ市場のタイプ別収益シェア（2022年、2028年）
  • 単層型薬物接着剤
  • 多層薬物接着剤
  • リザーバー
  • 蒸気パッチ
  • マトリックス

第8章 欧州の医療用経皮吸収パッチ市場：用途別収益と2028年までの予測

  • 医療用経皮吸収パッチ市場の用途別売上高シェア（2022年、2028年）
  • 神経疾患
  • 疼痛管理
  • ニコチン停止
  • 心血管疾患
  • ホルモン療法
  • その他

第9章 欧州の医療用経皮吸収パッチ市場：2028年までの収益と予測：流通チャネル別

  • 医療用経皮吸収パッチ市場の流通チャネル別収益シェア（2022年および2028年）
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第10章 医療用経皮吸収パッチ市場：2028年までの収益と予測：国別分析

  • 欧州

第11章 業界情勢

  • 成長戦略

第12章 企業プロファイル

  • Hisamitsu Pharmaceutical Co Inc
  • Medline Industries LP
  • Johnson & Johnson
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • UCB SA
  • Viatris Inc
  • Endo Pharmaceuticals Inc
  • Boehringer Ingelheim International GmbH

第13章 付録

図表

List Of Tables

  • Table 1. UK Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. UK Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 3. UK Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Germany Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Germany Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Germany Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. France Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. France Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 9. France Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Spain Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Spain Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Spain Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Italy Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Italy Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Italy Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Rest of Europe Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Rest of Europe Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Rest of Europe Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Recent Growth Strategies in Transdermal Medical Patch Market
  • Table 20. Glossary of Terms

List Of Figures

  • Figure 1. Europe Transdermal Medical Patch Market Segmentation
  • Figure 2. Europe Transdermal Medical Patch Market by Region
  • Figure 3. Europe Transdermal Medical Patch Market Overview
  • Figure 4. Matrix is The Largest Share of Type Segment in Europe Transdermal Medical Patch Market
  • Figure 5. Germany Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Europe: PEST Analysis
  • Figure 7. Europe Experts' Opinion
  • Figure 8. Transdermal Medical Patch Market Impact Analysis of Drivers and Restraints
  • Figure 9. Europe Transdermal Medical Patch Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. Europe Transdermal Medical Patch Market Revenue Share, by Type (2022 and 2028)
  • Figure 11. Single-Layer Drug In-Adhesive: Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Multi-Layer Drug In-Adhesive: Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Reservoir: Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Vapor Patch: Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Matrix: Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Europe Transdermal Medical Patch Market Revenue Share, by Application (2022 and 2028)
  • Figure 17. Neurologic Conditions: Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Pain Management: Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Nicotine Cessation: Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Cardiovascular Disorders: Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Hormonal Therapy: Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Others: Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Europe Transdermal Medical Patch Market Revenue Share, by Distribution Channels (2022 and 2028)
  • Figure 24. Hospital Pharmacies: Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Retail Pharmacies: Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Online Pharmacies: Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Europe: Transdermal Medical Patch Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 28. Europe: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
  • Figure 29. UK: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Germany: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. France: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Spain: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Italy: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Rest of Europe: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00028755

The Europe transdermal medical patch market is expected to grow from US$ 2,434.09 million in 2023 to US$ 3,079.58 million by 2028. It is estimated to register a CAGR of 4.8% from 2023 to 2028.

Increasing Prevalence of Chronic Diseases Fuels Europe Transdermal Medical Patch Market

Transdermal medical patches are used to administer medications to people suffering from chronic diseases such as heart disease, stroke, diabetes, cancer, obesity, and arthritis.

A cardiac patch provides an excellent platform for cell engraftment improvement. For example, a vascularized cardiac patch developed recently showed promising potential for treating ischemic heart injuries. Nitroglycerin transdermal patches are used to prevent angina (chest pain) episodes in people with coronary artery disease. It works by relaxing the blood vessels and reducing the stress on the heart, thereby lowering the need for oxygen. However, these patches cannot be used to treat angina attacks that have already begun.

Rivastigmine patch is used to treat dementia (memory loss) associated with mild, moderate, or severe Alzheimer's disease or mild-to-moderate dementia associated with Parkinson's disease. Rivastigmine and donepezil, which are cholinesterase inhibitors, exhibit a dose-response relationship, with higher doses of the drugs demonstrating greater efficacy. As a small, lipophilic, and hydrophilic molecule, rivastigmine is chemically well-suited for transdermal delivery. The technology underlying the rivastigmine patch contributes to its discreetly small and thin appearance. Thus, the rivastigmine patch enables quick and easy access to high-dose efficacy.

Therefore, the increasing prevalence of chronic diseases catalyzes the demand for medical patches.

Europe Transdermal Medical Patch Market Overview

The Europe transdermal medical patch market is segmented into the UK, Germany, Spain, Italy, and the Rest of Europe. In 2022, the UK held the largest share of the Europe transdermal medical patch market. The rising number of patients suffering from chronic conditions and viral diseases and increasing activities in research and development are the key factors propelling the market for transdermal medical patches. Also, the growing prevalence of chronic diseases are favoring market expansion.

Europe Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)

Europe Transdermal Medical Patch Market Segmentation

The Europe transdermal medical patch market is segmented into type, application, distribution channel, and country.

Based on type, the market is segmented into single-layer drug in-adhesive, multi-layer drug in-adhesive, reservoir, vapor patch and matrix. The matrix segment registered the largest market share in 2023.

Based on application, the Europe transdermal medical patch market is segmented into neurologic conditions, pain management, nicotine cessation, cardiovascular disorders, hormonal therapy, and others. The pain management segment held the largest market share in 2023.

Based on distribution channel, the Europe transdermal medical patch market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2023.

Based on country, the Europe transdermal medical patch market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the market share in 2023.

Boehringer Ingelheim International GmbH, Endo International Inc, Hisamitsu Pharmaceutical Co Inc, Johnsons and Johnsons, Medline Industries LP, Novartis AG, Teva Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc are the leading companies operating in the transdermal medical patch market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe transdermal medical patch market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe transdermal medical patch market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the transdermal medical patch market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Transdermal Medical Patch Market - by Type
    • 1.3.2 Europe Transdermal Medical Patch Market - by Application
    • 1.3.3 Europe Transdermal Medical Patch Market - by Distribution Channel
    • 1.3.4 Europe Transdermal Medical Patch Market - by Country

2. Transdermal Medical Patch Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Transdermal Medical Patch Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Europe PEST Analysis
  • 4.3 Expert's Opinion

5. Europe Transdermal Medical Patch Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
    • 5.1.2 Growing Consumption of Tobacco
  • 5.2 Market Restraints
    • 5.2.1 Recalls of Transdermal Medical Patches due to Drug Failure
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Strategic Initiatives
  • 5.4 Future Trends
    • 5.4.1 Advancements in Smart Patches and Three-Dimensional (3D)-Printed Patches
  • 5.5 Impact analysis

6. Transdermal Medical Patch Market - Europe Analysis

  • 6.1 Europe Transdermal Medical Patch Market Revenue Forecast and Analysis

7. Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Type

  • 7.1 Overview
  • 7.2 Transdermal Medical Patch Market Revenue Share, by Type (2022 and 2028)
  • 7.3 Single-Layer Drug In-Adhesive
    • 7.3.1 Overview
    • 7.3.2 Single-Layer Drug In-Adhesive: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Multi-Layer Drug In-Adhesive
    • 7.4.1 Overview
    • 7.4.2 Multi-Layer Drug In-Adhesive: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Reservoir
    • 7.5.1 Overview
    • 7.5.2 Reservoir: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Vapor Patch
    • 7.6.1 Overview
    • 7.6.2 Vapor Patch: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Matrix
    • 7.7.1 Overview
    • 7.7.2 Matrix: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Application

  • 8.1 Overview
  • 8.2 Transdermal Medical Patch Market Revenue Share, by Application (2022 and 2028)
  • 8.3 Neurologic Conditions
    • 8.3.1 Overview
    • 8.3.2 Neurologic Conditions: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Pain Management
    • 8.4.1 Overview
    • 8.4.2 Pain Management: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Nicotine Cessation
    • 8.5.1 Overview
    • 8.5.2 Nicotine Cessation: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Cardiovascular Disorders
    • 8.6.1 Overview
    • 8.6.2 Cardiovascular Disorders: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Hormonal Therapy
    • 8.7.1 Overview
    • 8.7.2 Hormonal Therapy: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Distribution Channels

  • 9.1 Overview
  • 9.2 Transdermal Medical Patch Market Revenue Share, by Distribution Channels (2022and 2028)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Retail Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Retail Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Online Pharmacies
    • 9.5.1 Overview
    • 9.5.2 Online Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

10. Transdermal Medical Patch Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Europe: Transdermal Medical Patch Market
    • 10.1.1 Overview
    • 10.1.2 Europe: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
      • 10.1.2.1 UK: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 UK: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.3 UK: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.1.4 UK: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.1.5 UK: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
      • 10.1.2.2 Germany: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Germany: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.3 Germany: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.2.4 Germany: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.2.5 Germany: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
      • 10.1.2.3 France: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 France: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.3 France: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.3.4 France: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.3.5 France: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
      • 10.1.2.4 Spain: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Spain: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.4.3 Spain: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.4.4 Spain: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.4.5 Spain: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
      • 10.1.2.5 Italy: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 Italy: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.5.3 Italy: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.5.4 Italy: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.5.5 Italy: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
      • 10.1.2.6 Rest of Europe: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Europe: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.6.3 Rest of Europe: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.6.4 Rest of Europe: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.6.5 Rest of Europe: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 Hisamitsu Pharmaceutical Co Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medline Industries LP
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Johnson & Johnson
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Novartis AG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Teva Pharmaceutical Industries Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 UCB SA
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Viatris Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Endo Pharmaceuticals Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Boehringer Ingelheim International GmbH
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms